Portugal
BIAL, with the slogan "Keeping life in mind," has been a prominent figure in the field of Health since its establishment in 1924. The company has a global presence, with its innovative pharmaceutical products available in over 50 countries. BIAL's core mission revolves around discovering and developing new therapeutic solutions to contribute to the improvement of human health and the overall quality of life.
The company's commitment to therapeutic innovation is evident through its substantial investment, consistently allocating more than 20% of its annual revenue to Research and Development (R&D). Primarily focusing on neurosciences and rare diseases, BIAL has established an ambitious R&D program to drive progress in these critical areas.
Headquartered in Portugal, BIAL has further expanded its reach with facilities across several countries, including Spain, Germany, United Kingdom, Italy, Switzerland, United States, Mozambique, Angola, Panama, and Ivory Coast. As a member of the “European Federation of Pharmaceutical Industries and Associations” (EFPIA), BIAL is deeply engaged in the global pharmaceutical community.
Moreover, BIAL has solidified its reputation through its support for various medical and scientific initiatives. The company's contributions, particularly through the BIAL Foundation, have been internationally recognized. Noteworthy events such as the BIAL Award in Biomedicine, the Prémio BIAL de Medicina Clínica, and Scientific Research Grants highlight BIAL's commitment to advancing healthcare globally.
For investors seeking opportunities in the biotechnology and healthcare industries, BIAL presents a compelling proposition based on its enduring legacy, global expansion, and unwavering commitment to innovation and quality.
For more information, please visit: www.bial.com For safety or product quality-related concerns, please contact: [email protected]
